Skip to content

US · SY · MEDICAL - HEALTHCARE INFORMATION SERVICES

So-Young International Inc. (SY) intrinsic value and stock valuation

$1.65as of 2026-11-21 · Mkt cap 274.23M

Data updated · price as of 2026-11-21

Fairly valuedIC value is within 20% of the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

So-Young International Inc. DCF and intrinsic value

InvestorsCraft values SY with the Chepakovich two-stage DCF model — currently rated fairly valued. How the model works · Run your own DCF prefilled from SY’s statements →

So-Young International Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Healthcare Information Services Beijing, BE 100102 soyoung.com

How the business is doing

Fiscal 2016–2025, USD

Revenue
$1.48B+2.7% 5y CAGRd
20162025
Net income
-$-235.7M
20162025
Free cash flow
-$-302.01M
20162025
Total equity
$1.67B-8.6% 5y CAGRd
20162025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2016–2025, USD
20252024202320222021
Revenue$1.48B$1.47B$1.5B$1.26B$1.69B
Operating income-$-259.21M-$-624.49M-$-61.05M-$-102.81M-$-32.57M
Net income-$-235.7M-$-589.53M$21.3M-$-65.55M-$-8.37M
EPSd-$-1.79M-$-4.39M$161.3K-$-474.86K-$-60.63K
Operating cash flow-$-105.39M-$-25.63M$22.5M-$-112.87M$84.3M
Capital expenditure-$-196.62M-$-62.55M-$-51.18M-$-15.71M-$-45.06M
Free cash flow-$-302.01M-$-88.18M-$-28.68M-$-128.58M$39.2M
Total assets$2.65B$2.74B$3.21B$3.2B$3.33B
Total debt$299.9M$239.9M$145.8M$71.3M$105.9M
Net debt-$-183.3M-$-347.87M-$-280.35M-$-623.16M-$-1.23B
Total equity$1.67B$1.96B$2.56B$2.61B$2.52B
Cash and short-term investments$937M$1.19B$1.33B$1.57B$1.74B
Income statement
20252024202320222021
Revenue$1.48B$1.47B$1.5B$1.26B$1.69B
Cost of revenue$774M$567.6M$544.3M$393.3M$327.9M
Gross profit$707.9M$899.1M$953.7M$864.6M$1.36B
Research and development expenses$133.3M$165M$203.5M$235.1M$286.6M
Selling, general and administrative expenses$833.8M$818.6M$811.2M$732.3M$1.04B
Other expenses$0.00$540M$0.00$0.00$65.9M
Operating expenses$967.1M$1.52B$1.01B$967.4M$1.4B
Cost and expenses$1.74B$2.09B$1.56B$1.36B$1.73B
Interest income$24.6M$46.5M$48.8M$28.9M$19.3M
Interest expense$0.00$0.00$0.00$0.00$0.00
Depreciation and amortization$57.2M$46.1M$46.1M$47.1M$30.1M
Ebitda-$-182.19M-$-38.39M$54M-$-39.99M$63.4M
Operating income-$-259.21M-$-624.49M-$-61.05M-$-102.81M-$-32.57M
Total other income/expenses, net$19.8M$36.4M$68.9M$15.7M$16.2M
Income before tax-$-239.4M-$-588.09M$7.87M-$-87.07M-$-16.41M
Income tax expense-$-770K-$-910K-$-18.07M-$-20.96M$21.2M
Net income-$-235.7M-$-589.53M$21.3M-$-65.55M-$-8.37M
Weighted average shares outstanding$131.6M$134.1M$133.2M$138M$138M
Weighted average diluted shares outstanding$131.6M$134.2M$131.9M$138M$138M
Balance sheet
20252024202320222021
Cash and short-term investments$937M$1.19B$1.33B$1.57B$1.74B
Net receivables$209.9M$226.3M$80.4M$170.3M$110.5M
Inventory$233.5M$151.8M$118.9M$120.5M$91.8M
Total current assets$1.49B$1.72B$1.72B$1.92B$2.03B
Property, plant and equipment, net$545.5M$318.1M$235.2M$179.1M$220.2M
Goodwill and intangible assets$144.9M$127.3M$686M$710M$734.7M
Long-term investments$274.9M$280.3M$261M$228M$252.5M
Total non-current assets$1.17B$1.01B$1.49B$1.28B$1.3B
Total assets$2.65B$2.74B$3.21B$3.2B$3.33B
Accounts payable$0.00$0.00$0.00$0.00$0.00
Short-term debt$116.4M$114.7M$59.6M$50.3M$43.5M
Deferred revenue$292.6M$190.4M$195.2M$181.7M$190.3M
Total current liabilities$784.6M$630.2M$540.4M$538M$712.4M
Long-term debt$183.5M$125.2M$86.2M$21M$62.4M
Deferred revenue, non-current$0.00$0.00$0.00$0.00-$-38.58M
Total non-current liabilities$196.9M$146.2M$112.8M$52M$100.9M
Capital lease obligations$260M$170.1M$116M$71.3M$105.9M
Total liabilities$981.4M$776.4M$653.3M$590M$813.3M
Common stock$290K$290K$280K$270K$270K
Retained earnings-$-1.18B-$-885.84M-$-330.17M-$-346.62M-$-272.37M
Accumulated other comprehensive income (loss)$59.8M$31.6M$52M$33.1M-$-63.56M
Total equity$1.67B$1.96B$2.56B$2.61B$2.52B
Total investments$728.7M$879.3M$1.16B$1.1B$661.5M
Total debt$299.9M$239.9M$145.8M$71.3M$105.9M
Net debt-$-183.3M-$-347.87M-$-280.35M-$-623.16M-$-1.23B
Cash flow statement
20252024202320222021
Net income-$-246.91M-$-587.18M$25.9M-$-66.11M-$-37.64M
Depreciation and amortization$57.2M$45.9M$46.1M$47.1M$30.1M
Stock-based compensation$8.92M$32.7M$36.3M$43.3M$106.2M
Change in working capital-$-26.11M-$-167.85M-$-122.44M-$-195M-$-164.54M
Accounts receivable$29.7M-$-61.48M-$-28.95M$13.6M$14.6M
Inventory-$-115.98M-$-36.75M-$-2.12M-$-27.99M$7.87M
Accounts payable$0.00$0.00$0.00$0.00-$-158.37M
Net cash provided by operating activities-$-105.39M-$-25.63M$22.5M-$-112.87M$84.3M
Investments in property, plant and equipment-$-196.62M-$-62.55M-$-51.18M-$-15.71M-$-45.06M
Acquisitions, net$0.00$0.00$0.00-$-97.49M-$-636.87M
Net cash used for investing activities-$-42.81M$257M-$-202.61M-$-572.21M$339.8M
Common stock issued$80K$0.00$0.00$0.00$0.00
Common stock repurchased-$-15.25M-$-18.24M-$-125.62M-$-15.12M-$-217.71M
Dividends paid-$-19.03M-$-43.57M$0.00$0.00$0.00
Net cash used for financing activities-$-63.7M-$-21.51M-$-100.02M-$-13.59M-$-216.74M
Net change in cash-$-213.38M$213.2M-$-268.26M-$-642.81M$198.1M
Cash at end of period$432.6M$646M$432.7M$701M$1.34B
Operating cash flow-$-105.39M-$-25.63M$22.5M-$-112.87M$84.3M
Capital expenditure-$-196.62M-$-62.55M-$-51.18M-$-15.71M-$-45.06M
Free cash flow-$-302.01M-$-88.18M-$-28.68M-$-128.58M$39.2M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About So-Young International Inc.

        So-Young International Inc. manages a digital platform specializing in medical aesthetics and elective healthcare services, serving customers in the People's Republic of China and globally. This online ecosystem enables users to explore content, share personal experiences regarding medical aesthetic procedures, and book in-person treatments with various medical aesthetic service providers. The platform also offers resources for researching treatment trends, features ratings and reviews of treatment experiences, and publishes blogs under headings like "Beauty Diaries." Beyond cosmetic enhancements, So-Young facilitates reservations for a broader spectrum of healthcare needs, including dermatology, dentistry (with orthodontics), ophthalmology, comprehensive physical examinations, gynecology, human papillomavirus vaccinations, and postnatal support. The company also supplies Software-as-a-Service (SaaS) solutions and provides guidance and training programs to medical service providers. Its offerings extend to internet information and technology advisory, management consulting, and internet culture services. Furthermore, So-Young is involved in the sale of medical equipment, equipment manufacturing, sales, and agency services, as well as microfinance. As of December 31, 2021, its platform had established connections with approximately 8,400 medical aesthetic service providers and an additional 5,000 providers offering other consumption-focused healthcare services. Established in 2013, So-Young International Inc. maintains its corporate headquarters in Beijing, China.

        CEO
        Xing Jin
        Employees
        2.35K
        Beta
        2.02

        Explore

        Frequently asked questions

        What is the intrinsic value of So-Young International Inc. (SY)?

        So-Young International Inc. (SY) is currently fairly valued based on the InvestorsCraft IC model — IC value is within 20% of the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is SY undervalued?

        SY trades at a price of $1.65 (Nov 21, 2026): fairly valued — IC value is within 20% of the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.